Nayaki Muthusamy

Nayaki Muthusamy, PhD has a diverse work experience spanning over several years. Nayaki currently works as a Senior Research Scientist at Annexon Biosciences since September 2022. Prior to that, they were a Senior Research Scientist at Applied Molecular Transport from June 2020 to May 2022. In this role, they led preclinical development for autoimmune and metabolic diseases, designed in vitro and in vivo studies, and participated in method transfer to CROs.

Before their role at Applied Molecular Transport, Nayaki worked at UCSF as a Postdoctoral Fellow from January 2010. There, they focused on cancer cell biology and characterized the regulation of signaling pathways involved in cancer progression and stemness. Nayaki also performed in vitro and in vivo experiments to assess cancer progression and studied receptor partitioning in clathrin and caveolin endocytic compartments.

Additionally, Nayaki gained experience during their graduate school at Vanderbilt University from 2004 to 2009. Nayaki studied protein and sterol trafficking in yeast and identified the relationship between flippase-phosphatidylserine flipping activities and cholesterol transporting function.

Throughout their career, Nayaki has demonstrated expertise in various areas, including preclinical development, in vitro and in vivo study design, receptor binding assays, and signaling pathway characterization. Nayaki has also contributed to publication and managed CROs for IND/FIH studies and clinical studies.

Nayaki Muthusamy, PhD completed their education in a chronological order. Nayaki earned a Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology from Vanderbilt University, attending from 2004 to 2009. Prior to that, they obtained a DVM degree from Madras Veterinary College. In addition to their educational background, Dr. Muthusamy also obtained a certification in FDA regulations on drug development from UC Berkeley in January 2015.